Official journal for @my_UEG, publishing high quality research in gastroenterology, hepatology and related fields. Free open access. NEW Impact factor: 6.7

Vienna, Austria
Joined March 2019
🤖AI improves detection & reporting of colonic angiodysplasia 🔸Detection: 94.5% accuracy, 84.4% sensitivity 🔸LLM reporting check: 95.8% accuracy 🔸AI detected 23 cases vs 5 physician-reported 📖 #OpenAccess 👉 bit.ly/4ikUFjW @my_ueg
1
1
76
📡Bowel urgency in #UlcerativeColitis is linked to deeper bowel wall changes 🔸56% reported urgency 🔸Sigmoid submucosal & muscularis propria thickening remained associated after endoscopic adjustment 🔸Mucosal thickness was not 📖 #OpenAccess 👉 bit.ly/4Bsxzk2
2
9
18
1,176
🧫Immune checkpoint inhibitor-induced pancreatitis is distinct from autoimmune pancreatitis 🔸Histology is heterogeneous 🔸Some cases overlap with type 2 AIP 🔸Pancreatic atrophy & exocrine insufficiency can develop 📖 #OpenAccess 👉 bit.ly/4zG8MY4 @my_ueg
1
12
30
1,454
🚻 Urge to defecate marks a higher-burden #IBS phenotype 🔸Urge: 80.9% in IBS vs 51.9% in controls 🔸Often overlaps with rectal pain & discomfort 🔸Not associated with IBS subtype or sex 📖 #OpenAccess 👉 bit.ly/4yCehpV @my_ueg
1
1
5
544
Community area now!! AI in publishing, YAY or NEY and if yes HOW, WHAT and WHEN??? @my_ueg #ueg2026
1
3
374
⏱️Immediate necrosectomy is not superior to an on-demand in #NecrotizingPancreatitis 🔸No clear benefit in clinical/technical success 🔸Adverse events & mortality similar 🔸Fewer stent migrations overall, not in RCT-only analysis 📖 #OpenAccess 👉 bit.ly/4jMrdpi
1
9
1
15
1,230
🧩Primary care #IBS carries a high symptom & psychosocial burden 🔸70% met Rome IV criteria; 77% had moderate-severe symptoms 🔸IBS-D & IBS-M were most common 🔸Rome IV-positive & IBS-M had greater symptom & psychosocial burden 📖 #OpenAccess 👉 bit.ly/4yGI5CP
1
4
8
874
🧬Familial/germline #PancreaticCancer risk is not linked to higher pancreatic fat 🔸AI matched expert radiologists closely 🔸Pancreatic fat: 25.8% vs 26.9% in controls 🔸Fat was linked to age, male sex, diabetes & BMI 📖 #OpenAccess 👉 bit.ly/47ehhxw @my_ueg
1
6
8
707
Pancreatic enzyme needs vary by aetiology. EURO-PEI (n=1,015): highest optimised doses after pancreatectomy & in pancreatic cancer. 46.9% of goal achievers needed doses above usual starting doses. Individualise PERT. doi.org/10.1002/ueg2.70282
1
4
18
1,022
Pancreatic enzyme needs vary by aetiology. EURO-PEI (n=1,015): highest optimised doses after pancreatectomy & in pancreatic cancer. 46.9% of goal achievers needed doses above usual starting doses. Individualise PERT. doi.org/10.1002/ueg2.70282
1
6
8
1,096
🏆 Introducing the @UEGJournal​​ Most Cited Article Award! Congratulations to the authors of articles 👏 🔹 Abdulbaqi Al-Toma 🔗 bit.ly/4d9lI06 🔹 Rogier Voermans 🔗 bit.ly/4jwRyYk 🔹 Karn Wijarnpreecha and @PojsakornDan​ 🔗 bit.ly/4lCn18Q
5
1
10
1,392
UEGJ retweeted
🧬 #Microlithiasis may trigger acute #pancreatitis via #NLRP3-driven papillitis 🔸Papillary biopsies showed ↑inflammation & NLRP3 🔸Cholesterol/bilirubinate crystals activated macrophage NLRP3 🔸Supports inflammation as a trigger 📖 #OpenAccess 👉 bit.ly/4vklLg9
1
11
1
30
2,724
UEGJ retweeted
🧭 #Ustekinumab offers a safety advantage after #vedolizumab failure in #UC 🔸 Similar remission rates with infliximab, anti-TNF SC & ustekinumab 🔸 Fewer adverse events and treatment discontinuations with ustekinumab 📖 #OpenAccess 👉 bit.ly/3SctjmK @my_ueg
2
23
1
55
3,807